CYPROHEPTADINE HYDROCHLORIDE
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- CYPROHEPTADINE HYDROCHLORIDE
- Generic name
- CYPROHEPTADINE HYDROCHLORIDE
- Manufacturer
- Atlantic Biologicals Corp.
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 582b86c6-f9b2-278d-e063-6394a90a923d
- SPL ID
- 5879a022-28c6-e608-e063-6294a90aee9f
- Version
- 2
- Effective date
- 2026-08-07
- Source export date
- 2026-09-28
- Source partition
- 7
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:48:20
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 212423 | derived:openfda.application_number |
| application number | ANDA212423 | openfda.application_number | |
| brand name | CYPROHEPTADINE HYDROCHLORIDE | openfda.brand_name | |
| generic name | CYPROHEPTADINE HYDROCHLORIDE | openfda.generic_name | |
| manufacturer name | Atlantic Biologicals Corp. | openfda.manufacturer_name | |
| ndc | package | 17856-1185-2 | openfda.package_ndc |
| ndc | package | 17856-1185-1 | openfda.package_ndc |
| ndc | product | 17856-1185 | openfda.product_ndc |
| ndc11 | package | 17856118501 | derived:openfda.package_ndc |
| ndc11 | package | 17856118502 | derived:openfda.package_ndc |
| rxcui | 866021 | openfda.rxcui | |
| spl id | 5879a022-28c6-e608-e063-6294a90aee9f | id | |
| spl set id | 582b86c6-f9b2-278d-e063-6394a90a923d | set_id | |
| unii | NJ82J0F8QC | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS Children: Overdosage of antihistamines, particularly in infants and children, may produce hallucinations, central nervous system depression, convulsions and death. Antihistamines may diminish mental alertness; conversely, particularly in the young child, they may occasionally produce excitation. CNS Depressants: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents. Activities Requiring Mental Alertness: Patients should be warned about engaging in activities requiring mental alertness and motor coordination, such as driving a car or operating machinery. Antihistamines are more likely to cause dizziness, sedation and hypotension in elderly patients.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS Adverse reactions which have been reported with the use of antihistamines are as follows: Central Nervous System: Sedation and sleepiness (often transient), dizziness, disturbed coordination, confusion, restlessness, excitation, nervousness, tremor, irritability, insomnia, paresthesias, neuritis, convulsions, euphoria, hallucinations, hysteria, faintness. Integumentary: Allergic manifestation of rash and edema, excessive perspiration, urticaria, photosensitivity. Special Senses: Acute labyrinthitis, blurred vision, diplopia, vertigo, tinnitus. Cardiovascular: Hypotension, palpitation, tachycardia, extrasystoles, anaphylactic shock. Hematologic: Hemolytic anemia, leukopenia, agranulocytosis, thrombocytopenia. Digestive System: Dryness of mouth, epigastric distress, anorexia, nausea, vomiting, diarrhea, constipation, jaundice. Genitourinary: Urinary frequency, difficult urination, urinary retention, early menses. Respiratory: Dryness of nose and throat, thickening of bronchial secretions, tightness of chest and wheezing, nasal stuffiness. Miscellaneous: Fatigue, chills, headache, increased appetite/weight gain. To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or www.FDA.gov/medwatch.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.